Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00480246 | A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer | PHASE1 | COMPLETED | - | — | — | May 1, 2007 | - | Jul 21, 2009 | 1 | Sweden |
| Name | Type | Description |
|---|---|---|
| BL 1020 | DRUG | - |
| Perphenazine | DRUG | - |
Inclusion Criteria: 1. Voluntarily signed written informed consent agreement approved by the Independent Ethics Committee (IEC) after explanation of the nature and objectives of the study and prior to any study specific procedure. 2. Healthy male subjects between the age of 21 and 35 (inclusive). 3...